<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Norway</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Norway.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/no.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Comparator-Dependent Safety Signals for Incident Systemic Autoimmune Rheumatic Diseases After mRNA COVID-19 Vaccination: A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080706-9ff137c3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080706-9ff137c3/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesis addresses ongoing clinical uncertainty regarding potential autoimmune complications following widespread mRNA immunization campaigns. Identifying the gap in extended monitoring frameworks underscores the necessity for sustained epidemiological tracking beyond immediate post-vaccination periods.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Expanding enhanced influenza vaccines programs for adults aged ≥65 in the Nordic region predicted to improve public health and health system resilience</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128934-45e5ca27/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128934-45e5ca27/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Scaling up advanced immunization protocols for senior citizens may reduce seasonal disease burden and alleviate pressure on medical facilities during peak viral circulation periods.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Antibodies against tick-borne pathogens in domestic dogs in Norway: Borrelia burgdorferi sensu lato, tick-borne encephalitis virus, and Anaplasma phagocytophilum.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s13028-026-00863-8-ce85973c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s13028-026-00863-8-ce85973c/</guid>
    <pubDate>Sun, 15 Mar 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate widespread canine exposure to tick-borne pathogens in Norway and support the use of dogs as sentinel species for assessing human risk from these pathogens.</description>
    <category>Lyme disease</category>
    <category>Tick-borne encephalitis</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Avian influenza overview June-September 2025.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9702-e49d9870/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9702-e49d9870/</guid>
    <pubDate>Mon, 27 Oct 2025 00:00:00 GMT</pubDate>
    <description>The data indicate that routine community exposure poses minimal threat, though individuals with professional or environmental contact with infected fauna face a marginally higher probability of contracting the virus.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Travel medicine</category>
    <category>One Health</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Tick-Borne Encephalitis (TBE) Vaccine in the National Immunisation Programme-For Whom, When and Where?</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-apa-70280-2f6f97a8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-apa-70280-2f6f97a8/</guid>
    <pubDate>Tue, 26 Aug 2025 00:00:00 GMT</pubDate>
    <description>Widespread adoption of the vaccine within national immunization schedules is advocated as a financially sustainable intervention that advances equitable protection for at-risk youth.</description>
    <category>Tick-borne encephalitis</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</guid>
    <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
    <description>The registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-ese-17-22-20183-en-1c0d334e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-ese-17-22-20183-en-1c0d334e/</guid>
    <pubDate>Thu, 31 May 2012 00:00:00 GMT</pubDate>
    <description>The findings provide comparative information about European vaccination strategies, suggesting that understanding diverse approaches may help countries adapt their programmes. High compliance has been achieved in many European programmes using only recommendations rather than mandates.</description>
    <category>Influenza</category>
    <category>Gastroenteritis</category>
    <category>Poliomyelitis</category>
    <category>Hepatitis B</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-esm-11-07-00635-en-e927caca/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-esm-11-07-00635-en-e927caca/</guid>
    <pubDate>Sat, 01 Jul 2006 00:00:00 GMT</pubDate>
    <description>Health authorities implemented enhanced surveillance and practitioner education in 2003. Following advisory board review in 2004, the Ministry of Health decided in 2006 to offer vaccination using a Norwegian outer membrane vesicle vaccine to persons aged 1 to 19 years in Seine-Maritime.</description>
    <category>Meningococcal disease</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
